Abstract
Diffuse optical tomography (DOT) is a safe and non-invasive medical imaging technique in which near-infrared (NIR) light (600 to 1000 nm) is transmitted between an array of sources and detectors positioned on the surface of the body and the properties of the measured light are used to reconstruct images of the optical properties of the intervening tissue. DOT has been successfully applied in numerous research areas requiring characterization of tissue composition and metabolism, including neuroimaging1,2 and musculoskeletal3 imaging, and has been proposed as an alternative or complementary technique to X-ray mammography for clinical breast imaging.4 Specifically, as the spectral attenuation of NIR light is strongly dependent on tissue physiology, DOT-measured biomarkers can be used to detect tumors,5 distinguish malignant tumors from benign tumors,6,7 and predict individual responses to neoadjuvant chemotherapy,8 without exposing the patient to ionizing radiation.

This publication has 42 references indexed in Scilit: